Yiu Huen Tsang

Oregon Health & Science University

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index19

i10-index21

Publications72

Citations3,410

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last latest available · showing 20 of 53

Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer
Cell Death and Disease · 2023-08-18 · 46 citations
Figures S1-S4 from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerPreprint
2023-03-31
Supplementary Methods from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplemental Table S1 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplemental Table S2 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Data from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplementary Methods from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplementary Figure S1 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplementary Table S3 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer
2023-03-31
Supplemental Table S1 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Tables S1-S6 from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerPreprint
2023-03-31
Supplemental Figure S3 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplemental Table S2 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplemental Figure S3 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplementary Figure S2 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Supplementary Figure S2 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Data from Engineering and Functional Characterization of Fusion Genes Identifies Novel Oncogenic Drivers of CancerPreprint
2023-03-31
Supplementary Table S3 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal Cancer
2023-03-31
Supplementary Figure S1 from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31
Data from Clinical and Functional Characterization of Atypical <i>KRAS</i>/<i>NRAS</i> Mutations in Metastatic Colorectal CancerPreprint
2023-03-31

Open author page on OpenAlex →